{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:31:15Z","timestamp":1794047475174,"version":"4.8.0"},"reference-count":15,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"10","license":[{"start":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T00:00:00Z","timestamp":1718841600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"DOI":"10.3324\/haematol.2024.285410","type":"journal-article","created":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T04:20:00Z","timestamp":1718857200000},"page":"3419-3425","source":"Crossref","is-referenced-by-count":6,"title":["&lt;i&gt;ASXL1\/TET2&lt;\/i&gt; genotype-based risk stratification outperforms &lt;i&gt;ASXL1&lt;\/i&gt; mutational impact and is independent of mutant variant allele fractions in chronic myelomonocytic leukemia"],"prefix":"10.3324","volume":"109","author":[{"given":"Clifford M.","family":"Csizmar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Gurney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmi","family":"Kanagal-Shamanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Hammond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terra L.","family":"Lasho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christy M.","family":"Finke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuya","family":"Natu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek A.","family":"Mangaonkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aref","family":"Al-Kali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naseema","family":"Gangat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayalew","family":"Tefferi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Alkhateeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Garcia-Manero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami S.","family":"Komrokji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najla A.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Padron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Montalban-Bravo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mrinal M.","family":"Patnaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2024,6,20]]},"reference":[{"key":"67670","doi-asserted-by":"crossref","unstructured":"Arber DA, Orazi A, Hasserjian RP. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022; 140(11):1200-1228.","DOI":"10.1182\/blood.2022015850"},{"key":"67671","doi-asserted-by":"crossref","unstructured":"Gelsi-Boyer V, Trouplin V, Roquain J. ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia. Br J Haematol. 2010; 151(4):365-375.","DOI":"10.1111\/j.1365-2141.2010.08381.x"},{"key":"67672","doi-asserted-by":"crossref","unstructured":"Coltro G, Mangaonkar AA, Lasho TL. Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)-a study of 1084 patients. Leukemia. 2020; 34(5):1407-1421.","DOI":"10.1038\/s41375-019-0690-7"},{"key":"67673","doi-asserted-by":"crossref","unstructured":"Itzykson R, Kosmider O, Renneville A. Prognostic score including gene mutations in chronic myelomonocytic leukemia. J Clin Oncol. 2013; 31(19):2428-2436.","DOI":"10.1200\/JCO.2012.47.3314"},{"key":"67674","doi-asserted-by":"crossref","unstructured":"Patnaik MM, Itzykson R, Lasho TL. ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients. Leukemia. 2014; 28(11):2206-2212.","DOI":"10.1038\/leu.2014.125"},{"key":"67675","doi-asserted-by":"crossref","unstructured":"Elena C, Gall\u00ec A, Such E. Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia. Blood. 2016; 128(10):1408-1417.","DOI":"10.1182\/blood-2016-05-714030"},{"key":"67676","doi-asserted-by":"crossref","unstructured":"Montalban-Bravo G, Kanagal-Shamanna R, Li Z. Phenotypic subtypes of leukaemic transformation in chronic myelomonocytic leukaemia. Br J Haematol. 2023; 203(4):581-592.","DOI":"10.1111\/bjh.19060"},{"key":"67677","doi-asserted-by":"crossref","unstructured":"Patnaik MM, Zahid MF, Lasho TL. Number and type of TET2 mutations in chronic myelomonocytic leukemia and their clinical relevance. Blood Cancer J. 2016; 6(9):e472.","DOI":"10.1038\/bcj.2016.82"},{"key":"67678","doi-asserted-by":"crossref","unstructured":"Gurney M, Greipp PT, Gliem T. TET2 somatic copy number alterations and allelic imbalances in chronic myelomonocytic leukemia. Leuk Res. 2023; 134:107391.","DOI":"10.1016\/j.leukres.2023.107391"},{"key":"67679","doi-asserted-by":"crossref","unstructured":"Mangaonkar AA, Swoboda DM, Coltro G. Clinicopathologic characteristics, prognostication and treatment outcomes for myelodysplastic\/myeloproliferative neoplasm, unclassifiable (MDS\/MPN-U): Mayo Clinic-Moffitt Cancer Center study of 135 consecutive patients. Leukemia. 2020; 34(2):656-661.","DOI":"10.1038\/s41375-019-0574-x"},{"key":"67680","doi-asserted-by":"crossref","unstructured":"Arber DA, Orazi A, Hasserjian R. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016; 127(20):2391-2405.","DOI":"10.1182\/blood-2016-03-643544"},{"key":"67681","doi-asserted-by":"crossref","unstructured":"Patnaik MM, Lasho TL, Vijayvargiya P. Prognostic interaction between ASXL1 and TET2 mutations in chronic myelomonocytic leukemia. Blood Cancer J. 2016; 6(1):e385.","DOI":"10.1038\/bcj.2015.113"},{"key":"67682","doi-asserted-by":"crossref","unstructured":"Zhao W, Zhang C, Li Y. The prognostic value of the interaction between ASXL1 and TET2 gene mutations in patients with chronic myelomonocytic leukemia: a meta-analysis. Hematology. 2022; 27(1):367-378.","DOI":"10.1080\/16078454.2021.1958486"},{"key":"67683","doi-asserted-by":"crossref","unstructured":"Such E, Germing U, Malcovati L. Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia. Blood. 2013; 121(15):3005-3015.","DOI":"10.1182\/blood-2012-08-452938"},{"key":"67684","doi-asserted-by":"crossref","unstructured":"Malcovati L, Della Porta MG, Strupp C. Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS). Haematologica. 2011; 96(10):1433-1440.","DOI":"10.3324\/haematol.2011.044602"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2024.285410\/77143","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2024.285410\/77591","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11659\/77143","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:06:45Z","timestamp":1794046005000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2024.285410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,20]]},"references-count":15,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2024.285410","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,20]]}}}